TVARDI THERAPEUTICS, INC. Common Stock, Share Subscribed but Unissued, Subscriptions Receivable
TVARDI THERAPEUTICS, INC. (TVRD) had Common Stock, Share Subscribed but Unissued, Subscriptions Receivable of $44.97 million as of 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable · last filed 2021-11-08
- 2021-09-30: Common Stock, Share Subscribed but Unissued, Subscriptions Receivable $44.97M.
- 2017-03-31: Common Stock, Share Subscribed but Unissued, Subscriptions Receivable $86.52M.
| Period end | Common Stock, Share Subscribed but Unissued, Subscriptions Receivable |
|---|---|
| 2021-09-30 | $44.97M 10-Q · filed 2021-11-08 |
| 2017-03-31 | $86.52M 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |